AUTHOR=Xu Qingjie , An Libing , Yang Haiqiang , Hong Keum-Shik 

TITLE=A multi-graph convolutional network method for Alzheimer’s disease diagnosis based on multi-frequency EEG data with dual-mode connectivity

JOURNAL=Frontiers in Neuroscience

VOLUME=Volume 19 - 2025

YEAR=2025

URL=https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2025.1555657

DOI=10.3389/fnins.2025.1555657

ISSN=1662-453X

ABSTRACT=ObjectiveAlzheimer’s disease (AD) is mainly identified by cognitive function deterioration. Diagnosing AD at early stages poses significant challenges for both researchers and healthcare professionals due to the subtle nature of early brain changes. Currently, electroencephalography (EEG) is widely used in the study of neurodegenerative diseases. However, most existing research relies solely on functional connectivity methods to infer inter-regional brain connectivity, overlooking the importance of spatial connections. Moreover, many existing approaches fail to fully integrate multi-frequency EEG features, limiting the comprehensive understanding of dynamic brain activity across different frequency bands. This study aims to address these limitations by developing a novel graph-based deep learning model that fully utilizes both functional and structural information from multi-frequency EEG data.MethodsThis paper introduces a Multi-Frequency EEG data-based Multi-Graph Convolutional Network (MF-MGCN) model for AD diagnosis. This method integrates both functional and structural connectivity to more thoroughly capture the relationships among brain regions. By extracting differential entropy (DE) features from five distinct frequency bands of EEG signals for each segment and using graph convolutional networks (GCNs) to aggregate these features, the model effectively distinguishes between AD and healthy controls (HC).ResultsThe outcomes show that the developed model outperforms existing methods, achieving 96.15% accuracy and 98.74% AUC in AD and HC classification.ConclusionThese findings highlight the potential of the MF-MGCN model as a clinical tool for Alzheimer’s disease diagnosis. This approach could help clinicians detect Alzheimer’s at earlier stages, enabling timely intervention and personalized treatment plans.